medigraphic.com
SPANISH

Revista Mexicana de Pediatría

ISSN 0035-0052 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 6

<< Back Next >>

Rev Mex Pediatr 2025; 92 (6)

Wolff-Parkinson-White syndrome as a cause of cardiogenic shock

Quintero-Aguirre E, García-Ortega WA, Herrera-Bazán C, Ramírez-Valencia CA
Full text How to cite this article 10.35366/122758

DOI

DOI: 10.35366/122758
URL: https://dx.doi.org/10.35366/122758

Language: Spanish
References: 19
Page: 227-231
PDF size: 1400.94 Kb.


Key words:

Wolf-Parkinson-White syndrome, electrocardiogram, shock, arrhythmia, supraventricular tachycardia, infant.

ABSTRACT

Introduction: arrhythmias should be considered as part of the diagnostic approach in patients with cardiogenic shock. We present a pediatric patient with Wolff-Parkinson-White (WPW) syndrome. Case presentation: a 2-month-old male infant was admitted with shock and persistent tachycardia, initially with suspected sepsis. He subsequently developed supraventricular tachycardia that was refractory to adenosine, requiring cardioversion. The electrocardiogram showed a short PR interval and a delta wave, confirming WPW syndrome. He responded favorably to propranolol. Conclusion: in a critically ill patient presenting with an arrhythmia, WPW syndrome should be considered to determine the appropriate treatment. Once the acute event is controlled, these patients should be followed by pediatric cardiology specialists.


REFERENCES

  1. Brissaud O, Botte A, Cambonie G, Dauger S, de Saint Blanquat L, Durand P et al. Experts' recommendations for the management of cardiogenic shock in children. Ann Intensive Care. 2016; 6(1): 14. doi: 10.1186/s13613-016-0111-2.

  2. Sánchez PI. Arritmias más frecuentes en la población infantojuvenil. Pediatr Integral. 2016; 20(8): 527-538. Disponible en: https://www.pediatriaintegral.es/wp-content/uploads/2016/xx08/03/n8-527-538_InmaSanchez.pdf

  3. Lucking SE, Maffei FA, Tamburro RF, Zaritsky A. Pediatric critical care: text and study guide. 2nd ed. Cham (Switzerland): Springer Nature; 2021. p. 498.

  4. Delacrétaz E. Clinical practice. Supraventricular tachycardia. N Engl J Med. 2006; 354(10): 1039-1051. doi: 10.1056/NEJMcp051145.

  5. Wren CH. Síndrome de Wolff-Parkinson-White. En: Wren CH. Guía concisa de arritmias pediátricas. Venezuela: AMOLCA; 2013. pp. 55-60.

  6. Wolff L, Parkinson J, White PD. Bundle-branch block with short P-R interval in healthy young people prone to paroxysmal tachycardia. Ann Noninvasive Electrocardiol. 2006; 11(4): 340-353. doi: 10.1111/j.1542-474X.2006.00127.x.

  7. Paerregaard MM, Hartmann J, Sillesen AS, Pihl C, Dannesbo S, Kock TO et al. The Wolff-Parkinson-White pattern in neonates: results from a large population-based cohort study. Europace. 2023; 25(7): euad165. doi: 10.1093/europace/euad165.

  8. Cain N, Irving C, Webber S, Beerman L, Arora G. Natural history of Wolff-Parkinson-White syndrome diagnosed in childhood. Am J Cardiol. 2013; 112: 961-965.

  9. Triedman JK. Management of asymptomatic Wolff-Parkinson-White syndrome. Heart. 2009; 95(19): 1628-1634. doi: 10.1136/hrt.2008.151175.

  10. Price JF, Kertesz NJ, Snyder CS, Friedman RA, Fenrich AL. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children < 1 year of age. J Am Coll Cardiol. 2002; 39(3): 517-520. doi: 10.1016/S0735-1097(01)01773-9.

  11. Etheridge SP, Escudero CA, Blaufox AD, Law IH, Dechert-Crooks BE, Stephenson EA et al. Life-threatening event risk in children with Wolff-Parkinson-White syndrome: a multicenter international study. J Am Coll Cardiol EP. 2018; 4(4): 445-447. doi: 10.1016/j.jacep.2017.10.009.

  12. Park MK, Guntheroth WG. How to read pediatric ECGs. 4th ed. Philadelphia: Mosby; 2006. Cap. 4, p. 50.

  13. Jung HJ, Young Ju H, Hyun MH, Lee SB, Kim YH. Wolff-Parkinson-White syndrome in young people, from childhood to young adulthood: relationships between age and clinical and electrophysiological findings. Korean J Pediatr. 2011; 54(12): 507-511. doi: 10.3345/kjp.2011.54.12.507.

  14. Luca AC, Curpan AS, Miron I, Horhota EO, Iordache AC. Paroxysmal supraventricular tachycardia in Wolff-Parkinson-White syndrome in a newborn - case report and mini-review. Medicina (Kaunas). 2020; 56(11): 588. doi: 10.3390/medicina56110588.

  15. Grueso J. Tratamiento farmacológico de las arritmias en niños. An Pediatr Contin [Internet]. 2007; 5(5): 283-288. Disponible en: https://www.elsevier.es/index.php?p=revista&pRevista=pdf-simple&pii=S1696281807741483&r=51

  16. Gillette PC, Garson A Jr, Kugler JD. Wolff-Parkinson-White syndrome in children: electrophysiologic and pharmacologic characteristics. Circulation. 1979; 60(7): 1487-1495. doi: 10.1161/01.CIR.60.7.1487.

  17. Yadav V, Thapa S, Gajurel RM, Poudel CM, Manandhar B, Sharma M et al. A Wolff-Parkinson-White (WPW) electrocardiographic pattern in asymptomatic patient – state-of-the-art-review. J Cardiol Cardiovasc Med. 2022; 7: 046-053. doi: 10.29328/journal.jccm.1001132.

  18. Sanatani S, Potts JE, Reed JH, Saul JP, Stephenson EA, Gibbs KA et al. The study of antiarrhythmic medications in infancy (SAMIS): a multicenter randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. Circ Arrhythm Electrophysiol. 2012; 5(5): 984-991. doi: 10.1161/CIRCEP.112.972620.

  19. Testa A, Ojetti V, Migneco A, Serra M, Ancona C, De Lorenzo A et al. Use of amiodarone in emergency. Eur Rev Med Pharmacol Sci. 2005; 9(3): 183-190. Available in: https://pubmed.ncbi.nlm.nih.gov/16080639/




Figure 1
Figure 2
Figure 3
Figure 4

2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Pediatr. 2025;92